How much funding has QuantumCyte raised?

QuantumCyte has raised $2.1M in total funding, most recently a Series A round.

Who are QuantumCyte's investors?

QuantumCyte's investors include SOSV, IndieBio, North South Ventures, Endless Frontier Labs.

When was QuantumCyte founded?

QuantumCyte was founded in 2013.

Where is QuantumCyte headquartered?

QuantumCyte is headquartered in Fremont, California, United States.

What industry is QuantumCyte in?

QuantumCyte operates in Biotech, Digital Pathology, Medical Diagnostics, Oncology.

How many employees does QuantumCyte have?

QuantumCyte has 11-50 employees.

QuantumCyte

Answers from every biopsy

Fremont, United States · Founded 2013 · $2.1M raised

Biotech

Digital Pathology

Medical Diagnostics

Oncology

Headquarters: Fremont, California
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: quantumcyte.com
Total Funding: $2.1M
Last Round: $1.1M Series AAug 2023
Rounds: 6

About

QuantumCyte is a Fremont, California-based biotechnology company pioneering next-generation automated microdissection pathology through its Cytomask platform. The company combines patented science and technology to link digital pathology with molecular analysis, enabling high-precision tissue analysis from biopsy samples. QuantumCyte has collaborated with Roche on molecular pathology applications for precision medicine.

Summary

QuantumCyte is a Biotech company based in Fremont, United States, founded in 2013. It has raised $2.1M in total across 6 rounds, most recently a $1.1M Series A round in Aug 2023. Investors include SOSV, IndieBio and North South Ventures.